The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosis.
Coerver E, Schoof L, Hogenboom L, Wessels M, van Ruyven P, van Samkar A, Mostert J, van Kempen Z, van Oosten BW, Wokke BH, Tallantyre E, Myhr KM, Torkildsen O, Killestein J, Smets I, Strijbis E.
Coerver E, et al. Among authors: torkildsen o.
Mult Scler Relat Disord. 2024 Nov;91:105900. doi: 10.1016/j.msard.2024.105900. Epub 2024 Sep 28.
Mult Scler Relat Disord. 2024.
PMID: 39369631
Free article.